Greater access to legal cannabis is associated with a significant drop in daily opioid use, suggesting that cannabis availability may reduce reliance on opioids for pain or other use.
How can cannabis legalization influence opioid use? This is what a recent study published in Drug and Alcohol Dependence hopes to address as a team of researchers investigated behavior connections between cannabis use and opioid use. This study has the potential to help scientists, medical professionals, legislators, and the public better understand the benefits of cannabis, including how it can help the opioid epidemic.
For the study, the researchers analyzed survey data collected from 28,069 individuals designated as people who inject drugs (PWID) during 2012, 2015, 2018, and 2022 across 13 states. The goal of the study was to compare medical cannabis and medical plus recreational cannabis use to opioid use. The respondents were asked to report their past 30-day use for both cannabis and opioids. In the end, the researchers found that users who subscribed to both medical plus recreational cannabis use compared to just medical cannabis use experienced a 9–11 percent decline in opioid use.
The study notes in its conclusions, “Cannabis legalization may shape daily opioid consumption among PWID, potentially reducing drug-related harms. Differences in cannabis use following legalization may reflect disparate impact by race, due to structural racism or other factors. Future research examining whether policy attributable changes in substance use manifest health benefits among PWID is critical to developing evidence-based cannabis reform.”



